Table 1.
Inhibitory protein | Function | Complementary receptors |
---|---|---|
Nogo-A | Remyelination inhibitor via the RhoA pathway |
Nogo-66 terminus: NgR1, p75, TROY and LINGO1 Amino-Nogo terminus: unknown |
MAG | Remyelination inhibitor via the RhoA pathway | NgR2, GT1b, NgR1, p75, TROY and LINGO1 |
OMgp | Remyelination inhibitor via the RhoA pathway | NgR1 |
Versican (CSPG2) | Important during inflammation as it interacts with inflammatory leukocytes and inflammatory cells recruiting chemokines. It also stabilizes perineuronal nets to stabilize synaptic connections. |
N-terminus: hyaluronan in the extracellular matrix (ECM) C-terminus: Ligands in ECM, especially tenascin [75] |
NI-35 | Nonpermissive growth factor in myelin | Unknown |
Ephrin B3 [71] | Inhibits remyelination | EphA4 |
Semaphorin 4D (Sema 4D) [71] | Inhibits remyelination | PlexinB1 |
Semaphorin 3A (Sema 3A) [76–78] | In scars in both PNS and CNS injuries | Nrp1, Nrp2, L1cam, Nrcam [79] |
NgR1 Neuronal Nogo-66 receptor 1, LINGO1 Leucine rich repeat and Immunoglobin-like domain-containing protein 1, p75 neurotrophin receptor, TROY Tumor necrosis factor receptor superfamily, member 19, RhoA Ras homolog family member A, MAG Myelin-associated glycoprotein, GT1b Trisialoganglioside protein, OMgp Oligodendrocyte-myelin glycoprotein, CSPG2 chondroitin sulfate proteoglycan core protein 2 or versican, ECM extracellular matix, NI-35 A CNS myelin-associated neurite growth inhibitor, EphA4 Ephrin type-A receptor 4, Nrp1 Neuropilin 1, Nrp2 Neuropilin 2, L1cam L1 cell adhesion molecule, Nrcam Neuronal cell adhesion molecule